BSP Pharmaceuticals S.p.A. was presented at the 1st Antibody Drug Conjugates Summit from February 25-26, 2016 in Vienna, Austria.This summit, organized by the Vonlanthen Group, was an innovative B2B event about protein modeling development and engineering advances, preclinical and clinical improvements, current ADC linker chemistry, improving preclinical and clinical translation and creating strong and scalable processes.
The summit put light on current challenges, best practices and the inside view of the future of ADCs. During the firs day of this summit, at 12:40 AM, Laura Santinelli our Technology Transfer Specialist held the speech: “Conjugation & Fill-Finish at the Same Site, an Innovative Approach to the Supply of ADCs“
